The prevalence of myopia is increasing extensively worldwide. The number of people with
myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 …

Several approaches have been investigated for preventing myopia progression in children
and teenagers. Among them, topical atropine has shown promising results and it is being …

Background: Myopia is one of the most common causes of vision impairment in children and
adults and has become a public health priority with its growing prevalence worldwide. This …

Aims To evaluate the efficacy and safety of 0.01% atropine eye-drops in controlling myopia
progression over 5 years. Methods Experimental, analytical, prospective, randomised and …

Introduction Atropine is an old-known drug which is gaining increasing attention due to the
myriad of therapeutic effects it may trigger on eye structures. Nevertheless, novel …

In recent decades, the prevalence of myopia has been on the rise globally, attributed to
changes in living environments and lifestyles. This increase in myopia has become a …

Purpose Myopia is associated with an increased risk of permanent vision loss. The caffeine
metabolite 7-methylxanthine (7-MX), licensed in Denmark since 2009 as a treatment to …

Oxidative stress, caused by the formation of free radicals, such as reactive oxygen species
(ROS), leads to cell and tissue degradation, contributing to various diseases and aging …

Emerging pollutants, also referred to as emerging contaminants, are substances that have
recently been recognized or are gaining attention due to their potential adverse impacts on …

Myopia is becoming increasingly common. By 2050 around 10% of the world's population is
expected to be highly myopic (<-5 diopters) and therefore particularly at risk of suffering from …